Skip to main content
. 2022 Jul 25;11(8):1437. doi: 10.3390/antiox11081437

Figure 4.

Figure 4

Schematic diagram of hyperoside (Hyp), which improves various liver diseases by reducing oxidative stress; CYP, cytochrome P450; Nrf2, nuclear factor erythroid 2-related factor 2; MAPK, mitogen-activated protein kinase; NFκB, nuclear factor kappa-light-chain-enhancer of activated B cells; HO-1, heme oxygenase-1; GCLC, glutamate–cystein ligase catalytic subunit; NQO1, NAD(P)H quinone dehydrogenase 1; TNF-α, tumor necrosis factor-alpha; IL-6, interleukin-6; ATF3, cyclic AMP-dependent transcription factor; HSC, hepatic stellate cell; and ECM, extracellular matrix.